All News | FDA

Advertising & Promotion

Jun 27, 2022
Oregon Issues Permanent Rules for Drug Sales Rep Licensing
Jun 20, 2022
FTC Enforcement To Focus on PBM Rebates and Fees
Jun 10, 2022
Washington Supreme Court: Direct-to-Consumer Advertising Does Not Dilute Learned Intermediary Doctrine
Jun 7, 2022
Third OPDP Untitled Letter of 2022 Cites Risk Presentation, Efficacy Claims
Jun 2, 2022
Pfizer Reaches Kansas Settlement Over Co-pay Coupon Program
May 26, 2022
Analysis Finds Drug Ad Spending Stagnant Since 2018
May 12, 2022
Revised AdvaMed Code on Interactions with HCPs Becomes Effective June 1
Apr 29, 2022
OPDP Researchers Will Conduct Tradeoff Analysis of Product Claims Made to Consumers and Physicians
Apr 18, 2022
Marketers Sentenced for Roles in Compounded Drug Kickback Scheme Through Oklahoma Pharmacy
Apr 18, 2022
District Court Dismisses Case Against Merck over Vaccine Marketing

Good Clinical Practice

Aug 19, 2022
OIG Audit Finds NIH-funded Trials Not Posting Results
Aug 12, 2022
SACHRP Asks for More Clarity in HHS Single IRB Guidance
Aug 1, 2022
SACHRP Recommends New Definitions of ‘Engagement’ and ‘Support’
Jul 29, 2022
Sponsor-investigator Receives FDA Warning Letter; BRANY Gets Determination Letter
Jul 24, 2022
Two More Clinical Trial Staff Plead Guilty to Falsifying Data
Jul 20, 2022
Abbott Funds Clinical Trial Diversity Program
Jul 13, 2022
AdvaMed Report Recommends Strategies for Boosting Diversity in Medical Technology Clinical Research
Jul 8, 2022
OHRP Issues Draft Guidance on Use of Single IRB for Cooperative Research
Jul 1, 2022
HBCU-Pharma Project Will Create Clinical Trial Centers of Excellence
Jun 27, 2022
HHS To Revise Research Misconduct Regulation

U.S. Food Labeling

Jul 22,2021
FDA Releases Preview of Planned Upcoming Labeling Guidances
Jul 8,2021
USDA Commits to Wholesale Review of ‘Product of USA’ Labeling
Jun 23,2021
FDA Updates Standard of Identity for Yogurt Products
Jun 15,2021
NOSB Will Meet in October
Jun 9,2021
Supplement Firm Asks Court To Dismiss Class Action
May 26,2021
AMS Releases Results of 2020 NOP Enforcement Activity
May 13,2021
FDA Undertakes Research on ‘Healthy’ Symbols as Prelude to Regulations
Apr 29,2021
FASTER Act Is Now Law; Adds Sesame to List of Major Allergens for Labeling
Apr 15,2021
Appellate Court Will Not Enjoin Missouri Meat Labeling Law
Apr 15,2021
FDA Offers Plan To Reduce Amount of Heavy Metals in Baby Food

FDA Regulation & Enforcement

Medical Devices

Copyright © Thompson FDA, a division of CBIS. All rights reserved.